{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-034774","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2024-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.958682+00:00","generated_at":"2026-06-04T17:21:12.123898+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Nasdaq panel grants Avenue Therapeutics extension to May 20, 2024 for listing compliance","bullets":["Nasdaq Hearings Panel granted extension through May 20, 2024 to meet stockholders' equity and bid price requirements.","Company must evidence closing bid price >= $1.00 for at least 10 consecutive business days by May 20, 2024.","Previously failed to regain compliance by Nov 15, 2023; delisting process had been stayed pending hearing.","No assurance of regaining compliance; company evaluating all available options."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-034774","json":"https://secwatch.observer/filing/0001104659-24-034774.json","markdown":"https://secwatch.observer/filing/0001104659-24-034774.md","text":"https://secwatch.observer/filing/0001104659-24-034774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000110465924034774/0001104659-24-034774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000110465924034774/tm248839d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T17:21:12.123898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}